Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias

Circulation: Arrhythmia and Electrophysiology

Volumn 7, Issue 6, 2014, Pages 1109-1115

  Crawford, Thomas ^a   Mueller, Gisela ^a   Sarsam, Sinan ^b   Prasitdumrong, Hutsaya ^a   Chaiyen, Naiyanet ^a   Gu, Xiaokui ^a   Schuller, Joseph ^a   Kron, Jordana ^a   Nour, Khaled A ^a   Cheng, Alan ^a   Yong Ji, Sang ^a   Feinstein, Shawn ^a   Gupta, Sanjaya ^a   Ilg, Karl ^a   Sinno, Mohamad ^a   Abu Hashish, Saddam ^a   Al Mallah, Mouaz ^a   Sauer, William H ^a   Ellenbogen, Kenneth ^a   Morady, Fred ^a   Bogun, Frank ^a   more..

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b DETROIT MEDICAL CENTER   (United States)

Author keywords

Delayed enhancement; Implantable cardioverter defibrillator; MRI; Sarcoid; Sarcoidosis; Sudden cardiac death; Ventricular tachycardia

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOTERIDOL;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DELAYED ENHANCEMENT; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE BIOPSY; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; PRIMARY PREVENTION; PRIORITY JOURNAL; SARCOIDOSIS; SECONDARY PREVENTION; AGED; CARDIOMYOPATHIES; CLINICAL TRIAL; COMPLICATION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART STROKE VOLUME; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; REGISTER; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TACHYCARDIA, VENTRICULAR; UNITED STATES; VENTRICULAR FIBRILLATION;

ADULT; AGED; CARDIOMYOPATHIES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SARCOIDOSIS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TACHYCARDIA, VENTRICULAR; UNITED STATES; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FIBRILLATION; VENTRICULAR FUNCTION, LEFT;

EID: 84925545693     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.113.000156     Document Type: Article

References (20)

1. Koplan BA, Soejima K, Baughman K, Epstein LM, Stevenson WG. Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation. Heart Rhythm. 2006;3:924-929.
2. Uusimaa P, Ylitalo K, Anttonen O, Kerola T, Virtanen V, Pääkkö E, Raatikainen P. Ventricular tachyarrhythmia as a primary presentation of sarcoidosis. Europace. 2008;10:760-766.
3. Fleming HA, Bailey SM. Sarcoid heart disease. J R Coll Physicians Lond. 1981;15:245-246, 249.
4. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; Heart Rhythm Society. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2013;127:e283-e352.
5. Hiraga H, Hiroe, M, Iwai, K. Guideline for diagnosis of cardiac sarcoidosis: Study report on diffuse pulmonary diseases The Japanese Ministry of Health and Welfare. 1993:23-24.
6. Diagnostic standard and guidelines for sarcoidosis. Jpn J Sarcoidosis Granulomatous Disorders. 2007;27:89-102.
7. Patel MR, Cawley PJ, Heitner JF, Klem I, Parker MA, Jaroudi WA, Meine TJ, White JB, Elliott MD, Kim HW, Judd RM, Kim RJ. Detection of myocardial damage in patients with sarcoidosis. Circulation. 2009;120:1969-1977.
8. Isner JM, Roberts WC. Right ventricular infarction complicating left ventricular infarction secondary to coronary heart disease. Frequency, location, associated findings and significance from analysis of 236 necropsy patients with acute or healed myocardial infarction. Am J Cardiol. 1978;42:885-894.
9. Amado LC, Gerber BL, Gupta SN, Rettmann DW, Szarf G, Schock R, Nasir K, Kraitchman DL, Lima JA. Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model. J Am Coll Cardiol. 2004;44:2383-2389.
10. Gonen M. Analysing Receiver Operating Characteristic Curves with SAS. SAS Institute; 2007.
11. Heagerty PJ. Package 'survivalROC': time-dependent roc curve estimation from censored survival data. 2013 (http://cran.r-project.org/web/packages/survivalROC/survivalROC.pdf).
12. Blanche P. Package 'timeROC': time-dependent roc curve and auc for censored survival data. 2012 (http://cran.r-project.org/web/packages/timeROC/timeROC.pdf).
13. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC, Jr., Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Riegel B, Tarkington LG, Yancy CW. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the american college of cardiology/american heart association task force on practice guidelines (writing committee to revise the ACC/AHA/naspe 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices): developed in collaboration with the american association for thoracic surgery and society of thoracic surgeons. Circulation. 2008;117:e350-e408.
14. Kron J, Sauer W, Schuller J, Bogun F, Crawford T, Sarsam S, Rosenfeld L, Mitiku TY, Cooper JM, Mehta D, Greenspon AJ, Ortman M, Delurgio DB, Valadri R, Narasimhan C, Swapna N, Singh JP, Danik S, Markowitz SM, Almquist AK, Krahn AD, Wolfe LG, Feinstein S, Ellenbogen KA. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis. Europace. 2013;15:347-354.
15. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC, Jr., Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the american college of cardiology/american heart association task force and the european society of cardiology committee for practice guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death): developed in collaboration with the european heart rhythm association and the heart rhythm society. Circulation. 2006;114:e385-e484.
16. Mehta D, Mori N, Goldbarg SH, Lubitz S, Wisnivesky JP, Teirstein A. Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation. Circ Arrhythm Electrophysiol. 2011;4:43-48.
17. Vignaux O, Dhote R, Duboc D, Blanche P, Devaux JY, Weber S, Legmann P. Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced, and cine magnetic resonance imaging: initial results of a prospective study. J Comput Assist Tomogr. 2002;26:762-767.
18. Smedema JP, Snoep G, van Kroonenburgh MP, van Geuns RJ, Dassen WR, Gorgels AP, Crijns HJ. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol. 2005;45:1683-1690.
19. Diagnostic standard and guidelines for sarcoidosis. Jpn J Sarcoidosis Granulomatous Disorders. 2007;27:89-102.
20. Schuller JL, Zipse M, Crawford T, Bogun F, Beshai J, Patel AR, Sweiss NJ, Nguyen DT, Aleong RG, Varosy PD, Weinberger HD, Sauer WH. Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis. J Cardiovasc Electrophysiol. 2012;23:925-929.